Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and
midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for …

Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Importance The natriuretic peptides are biochemical markers of heart failure (HF) severity
and predictors of adverse outcomes. Smaller studies have evaluated adjusting HF therapy …

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2011 and includes selected …

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Background: Natriuretic peptides (NP) have prognostic value in heart failure (HF), although
the clinical importance of changes in NP from baseline is unclear. Objectives: The authors …

In response to injury, hemodynamic changes, or neurohormonal activation, the heart
undergoes a series of structural and functional changes that have been termed cardiac …

Background—There is a growing demand to collect patients' experiences of their health
status (their symptoms, function, and quality of life) in clinical trials, quality assessment …

Objectives: This randomized controlled multicenter trial evaluated coenzyme Q10 (CoQ10)
as adjunctive treatment in chronic heart failure (HF). Background: CoQ10 is an essential …